Cargando…

Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice

Sulforaphane (SFN) can effectively induce nuclear factor E2–related factor 2 (Nrf2), and zinc (Zn) can effectively induce metallothionein (MT), both of which have been shown to protect against diabetic cardiomyopathy (DCM). However, it is unclear whether combined treatment with SFN and Zn offers bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiqun, Wang, Shudong, Wang, Wanning, Chen, Jing, Zhang, Zhiguo, Zheng, Qi, Liu, Quan, Cai, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714218/ https://www.ncbi.nlm.nih.gov/pubmed/31270951 http://dx.doi.org/10.1111/jcmm.14520

Ejemplares similares

Sex Differences in Progression of Diabetic Cardiomyopathy in OVE26 Type 1 Diabetic Mice
por: Tang, Xiaoqiang, et al.
Publicado: (2020)

Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice
por: Zhou, Shanshan, et al.
Publicado: (2018)

Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
por: Gu, Junlian, et al.
Publicado: (2017)

Impaired Albumin Uptake and Processing Promote Albuminuria in OVE26 Diabetic Mice
por: Long, Y. S., et al.
Publicado: (2016)

Combination of Broccoli Sprout Extract and Zinc Provides Better Protection against Intermittent Hypoxia-Induced Cardiomyopathy Than Monotherapy in Mice
por: Wang, Jiqun, et al.
Publicado: (2019)

HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice
por: Nayak, Bijaya K., et al.
Publicado: (2016)

Therapeutic Effect of MG132 on the Aortic Oxidative Damage and Inflammatory Response in OVE26 Type 1 Diabetic Mice
por: Miao, Xiao, et al.
Publicado: (2013)

Zinc Prevents the Development of Diabetic Cardiomyopathy in db/db Mice
por: Wang, Shudong, et al.
Publicado: (2017)

Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice
por: Zheng, Shirong, et al.
Publicado: (2016)

Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice
por: Xie, Zhonglin, et al.
Publicado: (2011)

Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
por: Reiniger, Nina, et al.
Publicado: (2010)

Uninephrectomy of Diabetic OVE26 Mice Greatly Accelerates Albuminuria, Fibrosis, Inflammatory Cell Infiltration and Changes in Gene Expression
por: Zheng, Shirong, et al.
Publicado: (2011)

Transcriptome-Based Analysis of Kidney Gene Expression Changes Associated with Diabetes in OVE26 Mice, in the Presence and Absence of Losartan Treatment
por: Komers, Radko, et al.
Publicado: (2014)

Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage
por: Liu, Quan, et al.
Publicado: (2014)

Karl-Ove Nielsen, W. Jentschke
por: CERN PhotoLab
Publicado: (1975)

Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways
por: Wang, Xiang, et al.
Publicado: (2022)

Exacerbation of diabetic cardiac hypertrophy in OVE26 mice by angiotensin II is associated with JNK/c-Jun/miR-221-mediated autophagy inhibition
por: Qian, Ling-Bo, et al.
Publicado: (2017)

Sulforaphane Attenuation of Type 2 Diabetes-Induced Aortic Damage Was Associated with the Upregulation of Nrf2 Expression and Function
por: Wang, Yonggang, et al.
Publicado: (2014)

Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2‐knockout mice
por: Huang, Shan, et al.
Publicado: (2021)

Sulforaphane prevents angiotensin II‐induced cardiomyopathy by activation of Nrf2 through epigenetic modification
por: Su, Xuling, et al.
Publicado: (2021)

The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy
por: Wang, Shudong, et al.
Publicado: (2016)

Renoprotection From Diabetic Complications in OVE Transgenic Mice by Endothelial Cell Specific Overexpression of Metallothionein: A TEM Stereological Analysis
por: Carlson, Edward C., et al.
Publicado: (2017)

Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Liu, Wenjuan, et al.
Publicado: (2018)

Relationships of the Trace Elements Zinc and Magnesium With Diabetic Nephropathy-Associated Renal Functional Damage in Patients With Type 2 Diabetes Mellitus
por: Feng, Jianan, et al.
Publicado: (2021)

The Role of Akt2 in the Protective Effect of Fenofibrate against Diabetic Nephropathy
por: Cheng, Yanli, et al.
Publicado: (2020)

The protective effect of sulforaphane on type II diabetes induced by high‐fat diet and low‐dosage streptozotocin
por: Tian, Shuhua, et al.
Publicado: (2020)

Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db/db T2DM mice
por: Xu, Zheng, et al.
Publicado: (2016)

4‐O‐methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK‐mediated cardiac lipid metabolism improvement
por: Zheng, Zongyu, et al.
Publicado: (2019)

Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
por: Bai, Yang, et al.
Publicado: (2015)

Silencing of NOD2 protects against diabetic cardiomyopathy in a murine diabetes model
por: Shen, Lin, et al.
Publicado: (2018)

Protective Effect of Lactobacillus rhamnosus GG and its Supernatant against Myocardial Dysfunction in Obese Mice Exposed to Intermittent Hypoxia is Associated with the Activation of Nrf2 Pathway
por: Xu, Hui, et al.
Publicado: (2019)

Pandora, a PAthway and Network DiscOveRy Approach based on common biological evidence
por: Zhang, Kelvin Xi, et al.
Publicado: (2010)

Correction: Oves M, et al. Graphene Decorated Zinc Oxide and Curcumin to Disinfect the Methicillin-Resistant Staphylococcus aureus. Nanomaterials 2020, 10(5), 1004
por: Oves, Mohammad, et al.
Publicado: (2020)

Diabetic Cardiomyopathy and Its Prevention by Nrf2: Current Status
por: Chen, Jing, et al.
Publicado: (2014)

Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice
por: Wu, Bin, et al.
Publicado: (2017)

Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis
por: Gu, Junlian, et al.
Publicado: (2018)

Zinc and Diabetic Retinopathy
por: Miao, Xiao, et al.
Publicado: (2013)

Sulforaphane as a Potential Protective Phytochemical against Neurodegenerative Diseases
por: Tarozzi, Andrea, et al.
Publicado: (2013)

Prevention of Diabetic Nephropathy by Sulforaphane: Possible Role of Nrf2 Upregulation and Activation
por: Cui, Wenpeng, et al.
Publicado: (2012)

Sulforaphane Protects the Liver against CdSe Quantum Dot-Induced Cytotoxicity
por: Wang, Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_01iu5ok1g9u59akgucmb1ifl2f